Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis.

about

Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes.Association between sodium glucose co-transporter 2 inhibitors and a reduced risk of heart failure in patients with type 2 diabetes mellitus: a real-world nationwide population-based cohort study.

P2860

Q55332339-DCBFC685-223E-4326-937A-A0AD5B0B1CEC Q55499603-0C6A660B-B1A5-469D-809D-5494C5BA50D5

P2860

Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis.

Item

http://www.wikidata.org/entity/Q41176211

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Heart failure hospitalization ...... vational, real-world analysis.

@en

type

Item

label

Heart failure hospitalization ...... vational, real-world analysis.

@en

prefLabel

Heart failure hospitalization ...... vational, real-world analysis.

@en

P1476

Heart failure hospitalization ...... vational, real-world analysis.

@en

P2093

Abiy Agiro

http://www.w3.org/2001/XMLSchema#string

Harry Weisman

http://www.w3.org/2001/XMLSchema#string

Jeff White

http://www.w3.org/2001/XMLSchema#string

John Barron

http://www.w3.org/2001/XMLSchema#string

Santosh Gautam

http://www.w3.org/2001/XMLSchema#string

Thomas Power

http://www.w3.org/2001/XMLSchema#string

P2860

SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?

Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: meta-analysis of randomized clinical trials with 55,141 participants

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015

Marginal structural models and causal inference in epidemiology

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study.

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Association of antidiabetic medications targeting the glucagon-like peptide 1 pathway and heart failure events in patients with diabetes.

P2888

s12933-017-0575-x

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12933-017-0575-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090930915

http://www.w3.org/2001/XMLSchema#string

P698

28756774

http://www.w3.org/2001/XMLSchema#string

P921

hospitalization

P932

5535291

http://www.w3.org/2001/XMLSchema#string

Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis.

about

P2860

P2860

Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P921

P932